Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Prevention Research

Abstract 5697: Cellular iron depletion weakens isothiocyanate-induced HO-1 upregulation

George Loo
George Loo
1Univ. of North Carolina, Greensboro, NC.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM10-5697 Published April 2010
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC

Abstract

Heme oxygenase-1 (HO-1) is an important cytoprotective gene, whose expression is known to be elevated in various carcinomas. Also, overexpression of HO-1 is known to inhibit apoptosis particularly in cancer cells. Interestingly, exposing cancer cells to certain chemopreventive agents such as isothiocyanates causes induction of HO-1, perhaps as an attempt by the cells to help them survive the stressful situation. However, it is not completely known what nutritive factors or related components in cancer cells influence HO-1 induction as caused by isothiocyanates. Thus, the aim was to test the hypothesis that adequate iron is needed to enable cancer cells to optimally express HO-1 when induced by isothiocyanates. In HCT-116 human colon adenocarcinoma cells, phenethylisothiocyanate and sulforaphane increased expression of HO-1 and also heme oxygenase activity. However, cells made iron-deficient with the iron chelator, desferrioxamine (DFO), and then exposed to isothiocyanates had much lower heme oxygenase activity. This suppressive effect of DFO on isothiocyanate-mediated induction of heme oxygenase activity was in association with repression of HO-1 protein and mRNA expression. The suppression by DFO of isothiocyanate-induced HO-1 upregulation was reversed upon replenishing the iron-deficient cells with the missing iron. Additionally, it was found that thiol antioxidants (glutathione and N-acetylcysteine) inhibited isothiocyanate-induced HO-1 upregulation, implying that the HO-1 upregulation involved an oxidant signaling pathway. Indeed, NADPH oxidase (NOX) inhibitors, namely, diphenyleneiodonium (DPI) and apocynin, and a superoxide scavenger (Tiron) inhibited isothiocyanate-induced upregulation of HO-1 as well. DPI was the most potent and also inhibited nuclear translocation of redox-sensitive Nrf-2, which is known to activate the HO-1 gene. These findings suggest the possibility that adequate amounts of iron, which at the atomic level can serve as the pivotal element of heme in NOX, must be present in the cells to permit what appears to be NOX-dependent upregulation of HO-1 by isothiocyanates. It is concluded that iron-deficient HCT-116 cells are less able to increase expression of cytoprotective HO-1 when exposed to isothiocyanates, which may make the cancer cells more susceptible to killing.

Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 5697.

  • ©2010 American Association for Cancer Research
Back to top
Cancer Research: 70 (8 Supplement)
April 2010
Volume 70, Issue 8 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 5697: Cellular iron depletion weakens isothiocyanate-induced HO-1 upregulation
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 5697: Cellular iron depletion weakens isothiocyanate-induced HO-1 upregulation
George Loo
Cancer Res April 15 2010 (70) (8 Supplement) 5697; DOI: 10.1158/1538-7445.AM10-5697

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 5697: Cellular iron depletion weakens isothiocyanate-induced HO-1 upregulation
George Loo
Cancer Res April 15 2010 (70) (8 Supplement) 5697; DOI: 10.1158/1538-7445.AM10-5697
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Prevention Research

  • Abstract LB-175: Gender and racial disparities in incidence trends of tobacco-related cancers from 2010 to 2013
  • Abstract LB-171: Throwing the 'book' at the cancer cell speciifically: A new paradigm and a new strategy for cancer prevention and cure
  • Abstract LB-168: Differential response to genistein on prostate cancer cells expressing different MnSOD variants
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-175: Gender and racial disparities in incidence trends of tobacco-related cancers from 2010 to 2013
  • Abstract LB-171: Throwing the 'book' at the cancer cell speciifically: A new paradigm and a new strategy for cancer prevention and cure
  • Abstract LB-168: Differential response to genistein on prostate cancer cells expressing different MnSOD variants
Show more 3

Poster Presentations - Mechanistic Insights into Cancer Prevention 3

  • Abstract 5690: Increased anti-tumor activity by novel systemic delivery and molecular targets of Tanshinone II A
  • Abstract 5674: Huachansu, an extract from toad skin, strongly enhances radiosensitivity of human lung cancer cell lines
  • Abstract 5678: Kavalactone yangonin induces autophagy, inhibits TSC-mediated translation initiation and acts synergistically with a kava chalcone flavokawain A on growth inhibition in bladder cancer UMUC-3 cells
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement